{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 Rubella Quantitative IgG Calibration Verification Material",
        "IMMULITE\u00ae 2000 H. pylori IgG Calibration Verification Material",
        "IMMULITE\u00ae 2000 Toxoplasma Quantitative IgG Calibration Verification Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K141772",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133128"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "June 30, 2014",
    "Summary Letter Received Date": "July 1, 2014",
    "Submission Date": "June 30, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Rubella IgG",
        "H. pylori IgG",
        "Toxoplasma Quantitative IgG"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE\u00ae 2000 Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Calibration Verification Material"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibration Verification Material",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2000 Rubella, H. pylori, and Toxoplasma Quantitative IgG Calibration Verification Materials for verifying calibration of associated immunoassays on IMMULITE 2000 systems",
    "Indications for Use Summary": "For in vitro diagnostic use in verification of calibration of IMMULITE Rubella Quantitative IgG, H. pylori IgG, and Toxoplasma Quantitative IgG assays on IMMULITE 2000 systems",
    "fda_folder": "Clinical Chemistry"
}